AiCure

Company profile

About AiCure

AiCure is a leading AI and advanced data analytics company specializing in clinical trial optimization through its flagship platform, H.Code. The company has pioneered AI-powered adherence verification technology trusted by pharmaceutical companies, contract research organizations (CROs), and healthcare providers to verify medication and clinical behavior adherence across the healthcare lifecycle. H.Code combines AI-powered computer vision, synchronous chat, and predictive analytics to remotely observe and assist trial participants through their smartphones, revolutionizing access and participation while improving statistical power and deepening understanding of the relationship between patient behavior and trial outcomes. The platform supports all types of clinical trials—traditional site-based, decentralized, fully virtual, or hybrid models—across any therapeutic indication. AiCure's technology has been deployed across more than 2,200 clinical trial sites in 46 countries, capturing over 1.5 million participant doses with a 92% participant retention rate. The company's research demonstrates that early medication adherence captured through H.Code can serve as a marker for participant retention, with their Clinical Site Services framework reducing early termination rates for adherent participants to just 7.8% across 28 phase I-IV clinical trials. AiCure serves seven of the top 10 global pharmaceutical companies and has been awarded 84 patents for its innovative approach to clinical trial patient engagement and adherence monitoring.

Company description · AiCure official website

Mission. Make the trial experience better, for everyone. H.Code is designed to be a bridge between your patients and your clinical team, making clinical trials more convenient and accessible for participants and more manageable and effective for clinical sites and study teams.